172 related articles for article (PubMed ID: 29301075)
1. Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS.
Kelley AR; Perry G; Bach SBH
ACS Chem Neurosci; 2018 Apr; 9(4):708-714. PubMed ID: 29301075
[TBL] [Abstract][Full Text] [Related]
2. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
Kaya I; Zetterberg H; Blennow K; Hanrieder J
ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
[TBL] [Abstract][Full Text] [Related]
3. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
4. Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains.
Kelley AR; Perry G; Castellani RJ; Bach SB
ACS Chem Neurosci; 2016 Mar; 7(3):261-8. PubMed ID: 26720297
[TBL] [Abstract][Full Text] [Related]
5. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
[TBL] [Abstract][Full Text] [Related]
6. Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer's Disease.
Kaya I; Brinet D; Michno W; Başkurt M; Zetterberg H; Blenow K; Hanrieder J
ACS Chem Neurosci; 2017 Dec; 8(12):2778-2790. PubMed ID: 28925253
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry Imaging in Alzheimer's Disease.
Ikegawa M; Kakuda N; Miyasaka T; Toyama Y; Nirasawa T; Minta K; Hanrieder J
Brain Connect; 2023 Aug; 13(6):319-333. PubMed ID: 36905365
[No Abstract] [Full Text] [Related]
8. Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry.
Ikegawa M; Nirasawa T; Kakuda N; Miyasaka T; Kuzuhara Y; Murayama S; Ihara Y
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907869
[TBL] [Abstract][Full Text] [Related]
9. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
[TBL] [Abstract][Full Text] [Related]
10. Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and α-synuclein toward in vivo analysis.
Kelley AR; Colley ME; Perry G; Bach SBH
J Mass Spectrom; 2018 Feb; 53(2):162-171. PubMed ID: 29111606
[TBL] [Abstract][Full Text] [Related]
11. Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer's disease.
Hong JH; Kang JW; Kim DK; Baik SH; Kim KH; Shanta SR; Jung JH; Mook-Jung I; Kim KP
J Lipid Res; 2016 Jan; 57(1):36-45. PubMed ID: 26538545
[TBL] [Abstract][Full Text] [Related]
12. GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.
Michno W; Wehrli PM; Zetterberg H; Blennow K; Hanrieder J
Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):458-467. PubMed ID: 30273679
[TBL] [Abstract][Full Text] [Related]
13. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J
J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796
[TBL] [Abstract][Full Text] [Related]
14. Spatial Lipidomics Reveals Region and Long Chain Base Specific Accumulations of Monosialogangliosides in Amyloid Plaques in Familial Alzheimer's Disease Mice (5xFAD) Brain.
Kaya I; Jennische E; Dunevall J; Lange S; Ewing AG; Malmberg P; Baykal AT; Fletcher JS
ACS Chem Neurosci; 2020 Jan; 11(1):14-24. PubMed ID: 31774647
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry.
Panchal M; Loeper J; Cossec JC; Perruchini C; Lazar A; Pompon D; Duyckaerts C
J Lipid Res; 2010 Mar; 51(3):598-605. PubMed ID: 19779135
[TBL] [Abstract][Full Text] [Related]
16. Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease.
Ollen-Bittle N; Pejhan S; Pasternak SH; Keene CD; Zhang Q; Whitehead SN
Acta Neuropathol; 2024 Jun; 147(1):105. PubMed ID: 38896306
[TBL] [Abstract][Full Text] [Related]
17. Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection.
Cournut A; Moustiez P; Coffinier Y; Enjalbal C; Bich C
Talanta; 2024 Feb; 268(Pt 2):125357. PubMed ID: 37951181
[TBL] [Abstract][Full Text] [Related]
18. Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry.
Rüfenacht P; Güntert A; Bohrmann B; Ducret A; Döbeli H
J Mass Spectrom; 2005 Feb; 40(2):193-201. PubMed ID: 15706631
[TBL] [Abstract][Full Text] [Related]
19. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
20. Ceramides and sphingomyelinases in senile plaques.
Panchal M; Gaudin M; Lazar AN; Salvati E; Rivals I; Ayciriex S; Dauphinot L; Dargère D; Auzeil N; Masserini M; Laprévote O; Duyckaerts C
Neurobiol Dis; 2014 May; 65():193-201. PubMed ID: 24486621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
